Tag: Pneumococcal polysaccharide vaccine

  • Vaccine update for Adults!

    WASHINGTON – The Food and Drug Administration says it has approved Pfizer Inc.‘s best-selling Prevnar 13 vaccine for use in preventing pneumococcal disease in adults age 50 and older.  The agency’s move on Friday was widely anticipated, coming a little over a month after a panel of federal health experts voted overwhelmingly to recommend the use…

  • To Test or Not to Test, that is the question!

    If you’re like most doctors, who doesn’t spend the winter months prescribing antibiotics and treating upper respiratory infections?  But when is it serious enough to pull the trigger on a detailed work-up for immunodeficiency? As with everything in medicine, when symptoms are outside of the “norm,” it’s time to intervene and start your work-up.  Consider…